Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Pulsed radiofrequency to shoulder nerves versus the brachial plexus for chronic post‑mastectomy shoulder pain

Official title: Role of Pulsed Radiofrequency of Shoulder Individual Nerves Versus Brachial Plexus in Management of Chronic Post Mastectomy Shoulder Pain: A Prospective Randomized Controlled Study

Run by Cairo University · NCT07002944 · Data updated 2026-11-12

This will test whether pulsed radiofrequency to the brachial plexus or to individual shoulder nerves helps reduce chronic shoulder pain after mastectomy.

More Shoulder Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment90 (estimated)
SponsorCairo University
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Cairo)
StatusRecruiting
StartedJune 3, 2025
Main results expectedJune 30, 2026
Study endsJune 30, 2026
Registry record updatedJune 4, 2025
Trial IDNCT07002944 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 years with chronic post‑mastectomy shoulder pain, BMI 20–40 kg/m2, ASA II–III, and ongoing pain despite up to 450 mg/day tramadol are the intended participants.

Probably not a fit

Patients who are pregnant, hemodynamically unstable, recently had a myocardial infarction, have local or systemic sepsis, psychiatric illness, or known contraindications to the procedures are unlikely to benefit or to be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial compares pulsed radiofrequency (PRF) applied to the brachial plexus versus PRF applied to individual shoulder nerves, with a control group, in patients with chronic post‑mastectomy shoulder pain. Adults meeting inclusion criteria are enrolled at Cairo University and receive image‑guided PRF interventions, with clinical follow-up to record pain and functional outcomes. Eligibility includes age 18–65, BMI 20–40 kg/m2, ASA II–III status, and persistent pain despite up to 450 mg/day tramadol. The approach is based on shoulder innervation from C5–C7 and builds on prior case reports of PRF for brachial plexus‑related neuropathic pain, while brachial plexus PRF for shoulder pain is a novel application.

Why it matters

Potential benefit: If successful, the procedure could provide longer-lasting, non‑opioid pain relief and improved shoulder function for people with chronic post‑mastectomy shoulder pain.

How similar studies have gone: PRF to the brachial plexus for shoulder pain is novel, but PRF has shown benefit in case reports and small series for other brachial plexus‑related and neuropathic upper‑limb pain.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age (18-65) Years.
* American Society of Anesthesiologists (ASA) physical status (II- III).
* Patients with post mastectomy shoulder pain.
* Body mass index (BMI): (20-40) kg/m2.
* Patients on maximum daily dose tramadol ( 450mg ) and still in pain

Exclusion Criteria:

* Patient refusal.
* Known sensitivity or contraindication to drugs used in the study.
* Pregnancy.
* Recent myocardial infarction.
* Hemodynamically unstable.
* Local and systemic sepsis.
* Psychiatric illness.

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.